Holen Sie sich die Stockscreener-App
4.49
7.23%
-0.35
Schlusskurs vom Vortag:
$4.84
Offen:
$4.88
24-Stunden-Volumen:
155.45K
Relative Volume:
1.87
Marktkapitalisierung:
$25.71M
Einnahmen:
$257.00K
Nettoeinkommen (Verlust:
$-3.07M
KGV:
-4.7129
EPS:
-0.9527
Netto-Cashflow:
$-1.40M
1W Leistung:
-5.47%
1M Leistung:
-11.09%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$4.33
$4.99
1-Wochen-Bereich:
$4.33
$4.99
52-Wochen-Spanne:
$4.00
$6.20
Optimi Health Corp Stock (OPTH) Company Profile
Compare OPTH vs TAK, TEVA, HLN, ZTS, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OPTH
Optimi Health Corp
|
4.49 | 27.71M | 257.00K | -3.07M | -1.40M | -0.9527 |
TAK
Takeda Pharmaceutical Co Adr
|
18.28 | 58.50B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
36.71 | 42.84B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.185 | 40.68B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
73.48 | 30.40B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
499.66 | 21.36B | 3.17B | 1.29B | 1.01B | 27.09 |
Optimi Health Corp Aktie (OPTH) Neueste Nachrichten
Optimi Health to Present at H.C. Wainwright Global Investment Conference - TipRanks
Optimi Health to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - Investing News Network
Optimi Health Corp. to Present at H.C. Wainwright 28th Annual Global Investment Conference in September 2026 - kalkine.ca
SRx Health Decided To Invest In A Psychedelic Drug Company That Just Went Public – Here’s What Aided The Decision - Stocktwits
Psychedelic-drug maker Optimi Health (OPTH) plans investor meetings in New York - Stock Titan
symbol__ Stock Quote Price and Forecast - cnn.com
Optimi Health Corp. Common Shares (NASDAQ: OPTH) Stock Price, News & Analysis - Kalkine
Optimi Health Stock Faces Renewed Pressure as Psychedelic-Sector Sentiment Weakens - kalkine.ca
Optimi Health (CN:OPTI) Drops 4.12% as Revenue Weakness, Funding Risk and Psychedelic-Sector Uncertainty Pressure Sentiment - kalkine.ca
Optimi Health (OPTH) lines up discounted share funding with new $100M facility - Stock Titan
Optimi Health Corp. SEC Filing (Aug 26, 2026) - Stock Titan
Optimi Health Sets Up US$100 Million Equity Line for Psychedelic Drug Expansion - TipRanks
3 Revenue Generating Psychedelics Stocks Retail Investors Are Screening Right Now - Yahoo Finance
Top Optimi Health (OPTH) Competitors 2026 - MarketBeat
Optimi Health Establishes $100 Million Equity Facility as Psychedelic Commercialisation Advances - Yahoo Finance
Optimi Health (OPTH) clears way for resale of shares over 3x its float - Stock Titan
Optimi Health (OPTH) Stock Chart and Price History 2026 - MarketBeat
Optimi Health (OPTH) secures US$100M equity line with convertible note sweeteners - Stock Titan
Optimi Health Corp. Establishes US$100 Million Discretionary Equity Line of Credit with Seven Knots - kalkine.ca
Optimi Health (OPTH) raises $20.7M, posts larger loss and builds cash buffer - Stock Titan
Optimi Health Corp. Announces Up to US$100 Million Equity Line of Credit with Seven Knots - Quiver Quantitative
Optimi Health Establishes Discretionary Equity Facility - Yahoo Finance
Norton Rose Fulbright advises Optimi Health on equity facility - Norton Rose Fulbright
Optimi Health Corp. announced that it expects to receive $101.5 million in funding from Seven Knots, LLC - marketscreener.com
Optimi Health Stock Slides 3.4% on August 11 — Is This Psychedelics Manufacturer Getting Interesting Again? - kalkine.ca
Optimi Health Corp (CN:OPTI) Shares Under Pressure as Psychedelic Market Uncertainty and Development Risks Weigh on Sentiment - kalkine.ca
Optimi Health Corp. (OPTH) investor reports 8.25% beneficial stake via Cathay Visions - Stock Titan
Optimi Health CEO Dane Stevens holds 456,347 shares after indirect purchase at CDN$ 6.7 - Bitget
Optimi Health (OPTH) CEO adds 3,800 shares at CDN$6.70 - Stock Titan
Optimi Health Corp. Revenue Breakdown – CSE:OPTI - TradingView
Optimi Health Corp. (OPTH) - Zacks Investment Research
Optimi Health Corp. (OPTH) Cash From Operations (Quarterly) - Zacks Investment Research
Optimi Health (OPTH) seeks approval for equity plan and new preferred shares - Stock Titan
Optimi Health Corp. Revenue Breakdown – BOATS:OPTH - TradingView
Optimi Health (CN:OPTI) Advances: Is the Psychedelics Trade Quietly Reawakening? - kalkine.ca
Optimi Health Corp. Revenue Breakdown – NASDAQ:OPTH - TradingView
Optimi Health to Enter Asian Market with PsiloThai Collaboration on Psilocybin Research - TMX Newsfile
OPTH|Optimi Health Ord Shs|Price:4.680|Chg%:-0.070 - TradingKey
Optimi Health (OPTH) CEO boosts stake with 18,700-share buy - Stock Titan
Optimi Health (OPTH) 10K Form and Latest SEC Filings 2026 - MarketBeat
Red Light Holland Announces Corporate Rebrand to Rhelion Life Sciences Corp - Yahoo! Finance Canada
Optimi Health Corp. (CN:OPTI) Faces Selling Pressure as Healthcare Sector Uncertainty Weighs on Investor Confidence - kalkine.ca
Optimi Health Completes First 2026 Production of MDMA and Psilocybin Capsules - TMX Newsfile
3 Psychedelic Stocks With Potential Clinical Trial Catalysts - Sahm
OPTH Price Today: Optimi Health Corp. Stock Price, Quote & Chart - mexc.co
Optimi Health Completes Commercial Psilocybin Production to Address Treatment-Resistant Depression in Australia - AOL.com
Optimi Health Announces Pricing of Oversubscribed US$15 Million Public Offering and Nasdaq Uplisting - AOL.com
Finanzdaten der Optimi Health Corp-Aktie (OPTH)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.24%
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):